Serial #79205569
DEAD

Serial Number

79205569

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79205569 Trademark

Serial Number: 79205569 • Registration: 5314395

Serial #79205569 is a trademark filed by NOVARTIS AG on January 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 3, 2017

Registration Date

October 24, 2017

Published for Opposition

August 8, 2017

Cancellation Date

May 10, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Apr 19, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 29, 2025 INTS
INVALIDATION PROCESSED
Mar 29, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 11, 2025 INTR
CANCELLED SECTION 71
May 10, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 24, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 16, 2018 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 1, 2018 FICS
FINAL DISPOSITION PROCESSED
Feb 1, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 24, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 24, 2017 R.PR
NOTIFICATION PROCESSED BY IB
Aug 18, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2017 TROA
REFUSAL PROCESSED BY IB
May 20, 2017 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 15, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 15, 2017 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 4, 2017 RFCS
REFUSAL PROCESSED BY MPU
May 4, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 4, 2017 RFCR
NON-FINAL ACTION WRITTEN
May 3, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
May 2, 2017 MAFR
ASSIGNED TO EXAMINER
Apr 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 21, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 20, 2017 REPR